- Home
- ADIL vs XELB Comparison
ADIL vs XELB Comparison
Compare ADIL & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- XELB
- Stock Information
- Founded
- ADIL 2010
- XELB 2011
- Country
- ADIL United States
- XELB United States
- Employees
- ADIL N/A
- XELB N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- XELB Multi-Sector Companies
- Sector
- ADIL Health Care
- XELB Miscellaneous
- Exchange
- ADIL Nasdaq
- XELB Nasdaq
- Market Cap
- ADIL 6.0M
- XELB 6.4M
- IPO Year
- ADIL 2018
- XELB N/A
- Fundamental
- Price
- ADIL $0.38
- XELB $1.36
- Analyst Decision
- ADIL Strong Buy
- XELB
- Analyst Count
- ADIL 1
- XELB 0
- Target Price
- ADIL $8.00
- XELB N/A
- AVG Volume (30 Days)
- ADIL 696.7K
- XELB 1.4M
- Earning Date
- ADIL 08-13-2025
- XELB 08-14-2025
- Dividend Yield
- ADIL N/A
- XELB N/A
- EPS Growth
- ADIL N/A
- XELB N/A
- EPS
- ADIL N/A
- XELB N/A
- Revenue
- ADIL N/A
- XELB $5,774,000.00
- Revenue This Year
- ADIL N/A
- XELB $53.01
- Revenue Next Year
- ADIL N/A
- XELB $20.46
- P/E Ratio
- ADIL N/A
- XELB N/A
- Revenue Growth
- ADIL N/A
- XELB N/A
- 52 Week Low
- ADIL $0.22
- XELB $0.95
- 52 Week High
- ADIL $1.30
- XELB $8.49
- Technical
- Relative Strength Index (RSI)
- ADIL 43.92
- XELB 52.44
- Support Level
- ADIL $0.37
- XELB $1.28
- Resistance Level
- ADIL $0.40
- XELB $1.20
- Average True Range (ATR)
- ADIL 0.02
- XELB 0.09
- MACD
- ADIL 0.00
- XELB 0.05
- Stochastic Oscillator
- ADIL 27.83
- XELB 89.42
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About XELB Xcel Brands Inc.
Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.